Dr Parthiv Shah, Dr Umang R Sachapara, Dr Nitin S. Patil
{"title":"Functional Outcome of Intra-Articular Hyaluronic Acid Injection in Osteoarthritis of Knee Joint","authors":"Dr Parthiv Shah, Dr Umang R Sachapara, Dr Nitin S. Patil","doi":"10.22376/ijlpr.2023.13.5.p255-p272","DOIUrl":null,"url":null,"abstract":"Osteoarthritis/Osteoarthrosis (OA) defines an idiopathic, slowly progressive disease of the diarthrodial (synovial)joints. Intra-articular - Hyaluronic acid has been proposed to have many therapeutic mechanisms of action in the OA knee,including shock absorption, joint lubrication, anti-inflammatory effects, chondroprotection, proteoglycan synthesis, and cartilagematrix alterations. Thirty-six patients were selected for the proposed study based on eligibility criteria, study period, andfeasibility. Patients with clinical symptoms of osteoarthritis were screened based on inclusion (grades 1 and 2) and exclusioncriteria (previous history of trauma). Patients with grade I or II Osteoarthritis based on Kellegren & Lawrence grading weretaken up for the study. After obtaining informed consent, a structured interview schedule was administered to obtaininformation on their background characteristics and clinical and functional outcome of Osteoarthritis using VAS (Visual AnalogueScale) and WOMAC (The Western Ontario and McMaster Universities Osteoarthritis Index) tools. Following this, theintervention was done. All the patients were given a single injection(6ml) of high molecular weight Hyaluronic acid. This studywas done to verify safety and feasibility. Our findings suggest that intra-articular hyaluronic acid is safe for use with kneeosteoarthritis. While local and minor adverse events related to hyaluronic acid injection occurred, all symptoms disappearedwithin 48 hours.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"29 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Life Science and Pharma Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22376/ijlpr.2023.13.5.p255-p272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Osteoarthritis/Osteoarthrosis (OA) defines an idiopathic, slowly progressive disease of the diarthrodial (synovial)joints. Intra-articular - Hyaluronic acid has been proposed to have many therapeutic mechanisms of action in the OA knee,including shock absorption, joint lubrication, anti-inflammatory effects, chondroprotection, proteoglycan synthesis, and cartilagematrix alterations. Thirty-six patients were selected for the proposed study based on eligibility criteria, study period, andfeasibility. Patients with clinical symptoms of osteoarthritis were screened based on inclusion (grades 1 and 2) and exclusioncriteria (previous history of trauma). Patients with grade I or II Osteoarthritis based on Kellegren & Lawrence grading weretaken up for the study. After obtaining informed consent, a structured interview schedule was administered to obtaininformation on their background characteristics and clinical and functional outcome of Osteoarthritis using VAS (Visual AnalogueScale) and WOMAC (The Western Ontario and McMaster Universities Osteoarthritis Index) tools. Following this, theintervention was done. All the patients were given a single injection(6ml) of high molecular weight Hyaluronic acid. This studywas done to verify safety and feasibility. Our findings suggest that intra-articular hyaluronic acid is safe for use with kneeosteoarthritis. While local and minor adverse events related to hyaluronic acid injection occurred, all symptoms disappearedwithin 48 hours.
骨关节炎/骨关节病(OA)是一种特发性、缓慢进展的腹泻(滑膜)关节疾病。关节内透明质酸被认为在OA膝关节中具有多种治疗机制,包括减震、关节润滑、抗炎作用、软骨保护、蛋白多糖合成和软骨基质改变。根据入选标准、研究期限和可行性,选择了36例患者参加拟议的研究。根据纳入(1级和2级)和排除标准(既往创伤史)筛选有骨关节炎临床症状的患者。I级或II级骨关节炎患者(Kellegren &劳伦斯的评分被用于这项研究。在获得知情同意后,使用VAS (Visual AnalogueScale)和WOMAC (The Western Ontario and McMaster university Osteoarthritis Index)工具进行结构化访谈,以获取他们的背景特征以及骨关节炎的临床和功能结果信息。在此之后,进行了干预。所有患者均给予高分子量透明质酸单次注射(6ml)。本研究是为了验证其安全性和可行性。我们的研究结果表明关节内透明质酸对于治疗膝关节炎是安全的。虽然发生了与透明质酸注射有关的局部和轻微不良事件,但所有症状在48小时内消失。